4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-22-022756
Options or other derivatives
- SVP Finance / Interim CFO acquired 167,768 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gerber Brianna · SVP Finance / Interim CFO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-12 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +100,460 | 100,460 | D |
| 2022-08-12 | Grant or award : show line 2 in the form Restricted Stock Unit | +67,308 | 67,308 | D |
Loading xslF345X03/wf-form4_166035275685057.xml…